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ABSTRACT 
 
Purpose: To compare the presenting symptoms and the outcomes of root canal therapy 
between HIV positive and HIV negative endodontic patients over a 6-12 month period. 
 
Methods: Fifty-nine HIV negative and 46 HIV positive patients presented for endodontic 
treatment. Signs and symptoms were noted and compared for both groups of patients, 
together with demographic data and CD4 counts for the HIV positive patients. 
Endodontic procedures were evaluated after an 18-month period. Endodontic treatment 
was assessed using clinical factors (palpation, percussion, sensitivity to hot and cold, 
swellings, excessive bleeding), and radiographic factors (periapical radiolucency, root 
resorption, periodontal ligament space). 
 
Results: There was no statistically significant difference in the preoperative presenting 
symptoms of endodontic infections/conditions between HIV positive and HIV negative 
patients. The prevalence of radiographic caries in the presenting teeth was only 24% in 
the HIV positive patients compared with 95% in the HIV negative patients. For the HIV 
positive patients, the treatment time required to resolution of the endodontic infection 
was nearly twice (113 minutes) that of the HIV negative patients (52 minutes). Amongst 
the HIV positive patients still experiencing symptoms at 18 months, pain was more 
severe in those patients with lower CD4 counts (significance at the 90% level of 
confidence). 
 
 xiii
Conclusion: Within the limitations of this study the following conclusions emerge: 
 
1. Although the success rate was lower over the period of this study in HIV positive 
patients, the rate is sufficiently high to warrant treatment. 
2. Patients who are HIV positive may present with more severe symptoms and 
during treatment more bleeding may be expected. 
3. In keeping with best practice for immuno-compromised patients, it would be 
advantageous to put HIV positive patients on antibiotic cover during treatment. 
4. The process of anachoresis may explain the high incidence of endodontic 
infections in teeth with no history of trauma or caries in the HIV positive group. 
 
 xiv
 xv
CHAPTER 1: ENDODONTICS 
 
Endodontics is “That branch of dentistry concerned with the morphology, physiology, 
and pathology of the human dental pulp and peri-radicular tissues. Its study and 
practice encompass the basic and clinical sciences including biology of the normal 
pulp, the aetiology, diagnoses, prevention, and treatment of diseases and injuries of 
the pulp and associated periradicular tissues.” 1 The purpose of this chapter is to 
introduce endodontics from a historical and clinically progressive perspective. 
 
1.1 A brief history of endodontics 
 
It is assumed that endodontics may have been practiced as early as the second or third 
century BPE. A skull found in the Negev Desert in Israel had a bronze wire in one of 
its teeth which may have been used to treat an infected pulp. Other evidence shows 
that pulp chambers were drained to relieve pain and pressure in the first century of the 
present era. Advancements in endodontic practice were halted by controversial 
opinions such as those of William Hunter, a physician who in 1910 accused the dental 
profession of contributing to ill health by the kind of dentistry practiced at the time, 
naming a long list of diseases which he attributed to oral sepsis from dentistry in 
general.2  
 
Although at that time there were apparently some scientific grounds for his assertions 
some members of the medical profession used Hunter’s opinion as a means of shifting 
responsibility to the dental profession for those diseases and illnesses for which there 
was no available cure. It was easier to order the removal of teeth in the hope that the 
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patient would benefit than to determine the cause and develop a remedy. The result 
was the wholesale extraction of teeth. In fact, some urged not only simple extraction 
but surgical removal. 2 Today it is widely agreed that dead or devitalized teeth should 
be extracted if they can no longer be retained.3 
 
It was only in the 1930s that an editorial appeared in the Dental Cosmos which 
rejected the claims of Hunter and the focal infection theory and defended the retention 
of pulpless teeth.  
 
“The policy of indiscriminate extraction of all teeth in which the pulps are involved 
has been practiced sufficiently long to convince the most rabid hundred percenter that 
it is irrational and does not meet the demands of either medical or dental 
requirements, and much less those of the patient. Now let us turn from the destructive 
policy, the path of least resistance, to the constructive, even though it be beset with 
more difficulties, it certainly offers more possibilities of making the masticatory 
apparatus a useful and helpful organ rather than a crippled and constant menace to the 
welfare of the patient”.2 
 
The rejection of Hunter’s claims laid the foundation for a more logical and 
conservative approach. Furthermore at this stage X-ray units were becoming available 
to dental practitioners which further helped to justify the retention of pulpless teeth. 
The introduction of X-rays was arguably the greatest leap in endodontic history. 2  
 
The first dental X-ray unit was adapted from a medical unit and was sold by the 
Victor X-ray Company in 1913, 3 years after Hunter’s lecture. A regular X-ray 
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machine as we know it today was not available to the dental profession until a year 
after the advent of the Coolidge tube in 1918. In the 1920s there were “dental X-ray 
studios, where a technician operated in the employ of a dentist. This was a 
convenience for dentists who did not have an X-ray machine and greatly helped in the 
diagnosis of endodontic treatment”.4 
 
A further advancement in endodontics was the introduction of effective anaesthetics 
in the 1930s.4 This made the invasive procedure more comfortable for patients.  
 
Interest in endodontics grew as scientists began to research the discipline. Their 
efforts and simultaneous scientific findings, such as from the use of bacterial cultures, 
proved the safety and efficacy of root canal treatment. Thus this allowed thousands of 
patients to save their teeth. In February 1943 The American Association of 
Endodontists was founded in Chicago.4 
 
In 1949, a landmark study by Zander and Glass reported the use of liquefied phenol of 
90% strength directly onto exposed pulps of human teeth prior to capping the wounds 
with either a thick creamy paste of calcium hydroxide in water or zinc-oxide eugenol 
(ZOE) cement. The idea of the study was to follow, by histology, the healing pattern 
and any new dentine formation. Their novel approach was to extract the experimental 
teeth after various time periods following the initiation of the test procedures.5 This 
study design, also employed by Bergenholtz and Goteborg in the same year,6 became 
the norm for experimental pulpal research. Cluster effects were balanced by using two 
teeth in each patient by which the healing responses to both capping measures could 
be compared in one and the same individual. Thus began the evolution of endodontic 
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research, though clearly at the time there seemed to have been no ethical 
considerations or barriers to using human tissue for scientific investigation. 
 
The scope of endodontics broadened to include surgical endodontics, hemi-section, 
intentional replantation, and endodontic implants. Biomechanical and technical, rather 
than mechanical instrumentation alone is now practiced and instrumentation has been 
simplified because of the availability of standardized instruments as well as rotary 
technology. Irrigation of the root canal serves several purposes not appreciated in the 
past. An effort is made to use mild but effective medicaments today, instead of what 
may have been highly irritating and caustic agents in the past e.g. EDTA has replaced 
the acids, and tissue-tolerant medicaments such as calcium hydroxide have replaced 
the phenols.4 
 
1.2 Pulp and periradicular pathosis and microbiology 
 
Chugal, Clive and Spangberg (2006) clearly opined that periapical pathosis had the 
strongest effect on treatment outcome.7 Apical periodontitis occurs as a consequence 
of pulpal infection following various insults to the dental pulp. The major irritants of 
the pulpal tissue can be divided into living and non-living irritants. The living irritants 
are various micro organisms and viruses. The nonliving irritants are mechanical, 
thermal, and chemical in nature.8  
 
A positive association was found between cases with endodontic signs and symptoms 
such as spontaneous pain, tenderness to percussion, pain on palpation, swelling and 
purulent exudates, and the concentration of endotoxins.30 Black-pigmented gram-
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negative bacteria in root canals of teeth with necrotic pulps have been associated with 
increased clinical signs.9 
 
Tables 1.1 and 1.2 are after Lopez-Marcos 21 who has outlined a classification system, 
based on Walton and Torabinejad’s classification in which he distinguished between 
pulpitis, necrosis, and degenerative pulp conditions. 
 
Table 1.1: Classification of pulp pathological conditions (after Lopez-Marcos) 15 
PATHOLOGY TYPE SYMPTOMS 
REVERSIBLE HYPERSENSITIVITY 
SEROUS SYMPTOMATIC PURULENT   
HYPERPLASTIC (pulp polyps) 
PULPITIS IRREVERSIBLE 
ASYMPTOMATIC ULCERATED 
PARTIAL PARTIALSYMPTOMATIC NECROSIS TOTAL ASYMPTOMATIC 
ATROPHIC 
CALCIFICATION- pulp stones (true/false) 
INTERNAL DENTINE RESORPTION 
FATTY 
HYALINE 
FIBROUS 
METAPLASTIC 
PULP 
DEGENERATION 
OTHER 
OTHERS 
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Table 1.2: Classification of periapical pathological conditions (after Lopez-
Marcos).15 
PATHOLOGY CONDITIONS ACCORDING TO TESTS:  
Thermal, Electrical, Palpation, Percussion  
REVERSIBLE 
APICAL 
PERIODONTITIS 
 
APICAL HYPERAEMIA 
SEROUS 
SYMPTOMATIC PURULENT 
GRANULOMATOUS 
SUPPURATED 
IRREVERSIBLE 
APICAL 
PERIODONTITIS 
ASYMPTOMATIC 
APICAL OSTEONECROSIS 
 
Bacteria in dental root canals play a decisive role in the development of chronic apical 
periodontitis, and their elimination is the ultimate aim of endodontic treatment of 
infected teeth.10 The isolation of bacteria from endodontic infection has been limited 
since not all bacteria can be cultured.11 Recent advances in molecular techniques 
based on direct amplification of 16S rDNA from DNA extracted from bacteria, have 
allowed bacterial samples to be characterized in their entirety, without the biases of 
culture.12 Therefore polymerase chain reaction is a more effective, efficient and user 
friendly technique in evaluating the microbiology within pulp and periradicular 
pathosis.  
 
1.3 Radiological features of apical periodontitis 
 
The need for radiographs in all aspects of dental treatment has been well established. 
In endodontics radiographs are essential both for diagnosis and treatment decisions. 
Diagnostic radiology involves not only identifying the presence and nature of pathosis 
but also determining root and pulp anatomy and characterizing and differentiating 
other normal structures. 
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Endodontic pathoses have four distinguishing radiographic characteristics that aid in 
differentiating them from non-endodontic pathoses: 1 
1. Apical lamina dura is absent, having been resorbed 
2. A droplet-shaped radiolucency at the apex 
3. The radiolucency remains at the apex regardless of the angulation of 
the cone 
4. A cause of pulpal necrosis is usually, but not always, evident. 
 
Other characteristics include the widening of the periodontal ligament space and 
mineral loss.13 According to Duker14, the diagnosis of chronic periapical periodontitis 
can often be made simply by observing a periapical radiolucency on a radiograph. 
McDougal has noted that subtle osseous changes in chronic apical periodontitis can be 
detected radiographically.15 Table 1.1 has been derived from many sources in order to 
summarize the origins of different radiographic appearances associated with pulpal 
pathology. 
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Table 1.3: The effects of different inflammatory processes on the apical tissues 
and the resultant radiographic appearances after inflammation of the pulp 
 
RADIOGRAPHIC APPEARANCESSTAGE OF 
INFLAMMATION
UNDERLYING INFLAMMATORY 
CHANGES
 
  
Initial acute 
inflammation 
Inflammatory exudates accumulate in 
the apical periodontal space  
The tooth becomes tender   
The patient avoids biting on the tooth  
Widening of the radiolucent line of 
the periodontal ligament space 
Or 
No apparent changes 
Initial spread of 
inflammation 
Resorption and destruction of the 
apical bony socket 
At apex - Loss of the radiopaque line 
of the lamina dura. 
Continued spread of 
inflammation 
Continued  resorption and destruction 
of the apical alveolar bone 
At apex - Area of bone loss. 
Initial low-grade 
chronic inflammation 
Minimal destruction of the apical 
bone. 
The body’s defense systems lay down 
dense bone in the apical region 
At apex - No apparent bone 
destruction but dense sclerotic bone 
evident. 
Final stages of chronic 
inflammation 
Apical bone is resorbed and 
destroyed and simultaneously,  
the body’s defense systems try to 
confine the spread of infection by 
laying down dense bone around the 
area of resorption. 
Thus both processes are occurring 
simultaneously. 
At apex - Circumscribed, well 
defined radiolucent area of bone loss, 
surrounded by sclerotic bone, 
periapical granuloma or cyst. 
 
 
1.4 Clinical manifestations and diagnosis 
 
Pulpal diagnosis is made on the basis of clinical signs and symptoms, diagnostic tests 
and a comprehensive knowledge of the reaction of the pulp to irritants. Pulpal pain 
symptoms occur with different intensities and these differences often aid the clinician 
in establishing the proper diagnosis or treatment plan and in determining whether the 
pulp can be salvaged. The pain process occurs mainly while tissue damage is 
occurring. 16 
 
According to Siqueira and Barnett recent clinical evidence indicates that when pain is 
severe, or when mild to moderate pain is present with a previous history of aching 
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pain in the tooth, with or without periapical radiolucency, the tooth is in the 
irreversible painful pulpitis category.17 On the other hand, when clinical evidence 
indicates that the pain is mild to moderate with no previous history of pain, with 
normal pulp vitality, and there is no positive percussion sign, the pulp is in the 
reversible painful pulpitis category. Klausen, Halbo and Dabelsteen found that 
symptoms of constant pain, tenderness to temperature changes, “the tooth feels 
extruded”, impaired mouth opening, tenderness to palpation in the apical area, and 
mobility, were diagnostic of irreversible pulpitis.18 
 
However Seltzer, Bender and Nazimov have shown that the histopathologic status of 
the pulp in vital teeth cannot be determined by considering only a patient’s pain 
symptoms. Subjective questioning of symptoms as well as clinical examination and 
pulp testing remain their main diagnostic regimen.19 Various methods of pulpal 
evaluation do not dictate treatment but provide information that can be used with 
other information (history and radiographs) to establish a diagnosis. No one test in 
itself can be used to support a likely diagnosis. Nusstein and Beck reported that the 
number of days the patient had been in pain before seeking treatment was 
significantly greater for patients with irreversible pulpitis than for those patients with 
necrotic pulps.20 According to Lopez-Marcos, a significant relationship exists 
between pre-endodontic and post-endodontic pain. Patients with severe preoperative 
pain tended to have more severe operative and postoperative pain than patients with 
mild or no preoperative pain.21  
 
Clinical tests can be classified into peri-radicular tests, pulpal tests and tests for tooth 
fracture (table 1.2) can be used together with radiographs, to assist with diagnosis.  
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 Table 1.4: Classification of endodontic tests 
Pulpal tests Peri-radicular 
tests 
Tooth fracture 
test 
Thermal  Percussion  White light 
Electrical  Palpation  Visual 
Tests cavity Mobility  
 
Thermal test: this is usually made with ethyl chloride or sometimes hot gutta-percha 
on the tooth of concern. The tooth is isolated with a rubber dam so that the cold ethyl 
chloride/hot gutta percha will be confined to that tooth. When the cold/hot stimulus is 
used, one must try to determine if the effect of stimulus application produces a 
lingering effect or if the pain subsides immediately on removal of the stimulus from 
the tooth. The lingering quality of pain to a tooth after the stimulus is removed, is 
taken as evidence for irreversible pulpitis. If pain subsides immediately after the 
stimulus is removed, reversible pulpitis is the more likely diagnosis.  
 
Menke and Bender stated that the application of heat has a biphasic effect. First, the 
initial heat application evokes a rapid, brief pain response due to the rapid fluid 
movement caused by sudden temperature change. As the heat application is 
continued, there is a period of pain cessation followed by a more intense pain. This 
was presumed to be due to the dilatation of blood vessels caused by heat with a 
transient increase in intrapulpal pressure.22, 23 
 
The application of a cold stimulus to the clinical crown evokes a rapid A-delta pain 
response followed by an immediate pain cessation. Continuous cold application 
compromises the blood flow due to vasoconstriction of the blood vessels and causes 
anoxia, a condition under which A-delta fibers cease to function.  
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 Selden stated that it is clinically recognized that emerging thermal sensitivity is often 
a sign of pulpal pathosis. The consistent scenario is the fact that the “sick” tooth will 
first be sensitive to a cold thermal stimulus. With a continuing pulpal deterioration, it 
often leads to a change in sensitivity to hot stimuli. Eventually cold will stop the heat-
induced pain.24  
 
Electric pulp test: this is based on the use of an electric current to stimulate the nerve 
fibers within the tooth thereby representing the sensation of pain. However it is 
important to remember that a recently erupted tooth frequently gives a false negative 
response. Whilst thermal stimuli evoke pain due to fluid movement in the dentinal 
tubules, electric stimuli evoke a pain response due to ionic movement. Electric pulp 
testing only excites the A-delta fibers.25 According to Nam et al during electrical pulp 
testing, an electric current stimulates the intradental nerve fibers, which may be 
painful and stressful to the patient. A consistent negative response during testing 
indicates a necrotic pulp.26  
 
Electric pulp testing has shown that there are regional differences in dentinal pain. 
The differences in response depend on the nerve densities located in different regions 
of the pulp. In areas of high nerve density, the pulpal reaction to the electric pulp 
tester is more severe. The lowest response threshold is present at the incisal edge or 
the incisal one-third facial region, followed by the mid-third region. The highest 
response threshold is at the cervical third.18  
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The electric pulp tester is a valuable diagnostic aid in assessing the vitality of the 
dental pulp but its use whilst wearing examination gloves is a controversial issue. 
Some believe that one should not wear examination gloves during the procedure27 
whilst others advocate the use of gloves for reasons of cross contamination and 
infection.28 Kolbinson and Teplisky advocated that as long as the patient completes 
the circuit by holding the metallic handle of the electric pulp tester’s probe, dentists 
can easily, reliably, and accurately use the electric pulp tester while wearing 
examination gloves.29 The electric pulp tester is an excellent measure to test the 
vitality of an endodontically involved tooth. However the operator must ensure that 
the instructions for use of the pulp tester are followed accurately to ensure clarity and 
ease of use.  
 
Percussion: this test is merely used to find the problem tooth. Percussion involves 
gentle tapping with the back of a mirror handle, on the incisal/occlusal surface of 
several teeth in the area in question. In one study acute apical periodontitis had the 
characteristic of pain to percussion, whereas chronic apical periodontitis had no pain 
to percussion.23 However, another study reported no difference, 16 so clearly this test 
has little diagnostic value on its own and the final diagnosis requires additional 
information gained from other tests. 
 
Palpation: this refers to the detection of sensitivity to finger pressure on the mucosa 
over the apex of a tooth, buccal or lingual, and signals the further spread of 
inflammation from the periodontal ligament to the periosteum overlying the bone. 
This examination is most effective when it can be made bilaterally at the same time.2  8
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One study found that patients with necrotic pulps rated palpation pain as being more 
severe than did those with irreversible pulpitis.20 However, in the absence of any other 
comparative studies, palpation can only be used to confirm inflammatory spread to the 
periosteum. 
 
Radiographic examination: this is usually the last test, and the radiographic features of 
pulpitis have been discussed above. 
 
Two clinical tests together with the radiographic examination usually provide 
sufficient evidence to make an informed diagnosis.30  
 
1.5 Treatment 
 
1.5.1 Introduction 
 
The majority of patients who require root canal treatment will have been diagnosed as 
suffering from periradicular periodontitis.30 A fundamental principal of treatment is 
the identification and removal of the causative factors in the disease process. In 
conventional apical periodontitis it appears that microbiological factors are the 
aetiological factor. With this in mind, clinical management of microbial factors should 
essentially be the focus of root canal therapy. Thus an essential requirement during 
root canal treatment is the provision of a sterile environment where further 
contaminating micro-organisms can be excluded from the canal. The use of rubber 
dam as well as sterile instrumentation is therefore essential. Rubber dam was first 
developed and used in the 19th century by Barnum.31 Since then it has become 
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mandatory during root canal procedures because irrigation solutions have toxic effects 
on the soft tissue around the teeth. Furthermore optimum results are obtained for all 
dental procedures if the working area is protected from contamination by saliva.32 
Failure of asepsis will have a direct bearing on the outcome of treatment for the 
patient.  
 
Root canal therapy comprises three actions, cleaning, shaping and obturation. 
Cleaning is debridement, whereas shaping is preparing the canal for obturation. 
Cleaning depends on proper access cavities that provide straight-line access, and 
requires the action of both intracanal instruments and irrigants. Files should contact 
and plane as many walls as possible to loosen the debris. This is followed by 
irrigation, which functions to flush out the debris from the canal space. Obturation of 
the canal depends on how well the canal is shaped as well as the condensing 
instruments used for obturation.3  1
 
1.5.2 Debridement 
 
A recent innovation has been in the field of mechanical debridement such as the use 
of rotary instrumentation and systems such as Hero® Taper (Micro-Mega, Bresanton, 
France), NiTi (Micro-Mega, Bresanton, France) and EndoEze® (Ultradent, South 
Jordan, USA). Rotary instrumentation has afforded greater ease and speed of the 
procedure. Although one study showed that conventional hand filing with k-files was 
more effective in eliminating bacteria from the root canal, as compared with nickel-
titanium rotary instrumentation,33 another showed that bacteria were significantly 
reduced by the use of nickel-titanium rotary instrumentation.34 Generally the shape 
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and rotation of rotary instrumentation is considered to be far superior in the 
elimination of bacteria compared with conventional hand instrumentation.3  3
 
Comparative studies of the various types of nickel-titanium rotary instrumentation 
have been published. In two studies the design of the cutting blade of the Hero system 
was the most effective in removing the smear layer and produced the most changes in 
the cross sectional area of the root canal when compared with the Profile 
(Dentsply/Maillefer, Ballaigues, Switzerland) and K3 (SybronEndo, 
Sybron Dental Specialties, California, USA) instrumentation systems.32,35 In a 
different study, the Hero rotary system transported canals less and had better centering 
ability than the conventional stainless-steel k-files.36  
 
1.5.3 Irrigation and Medication 
 
Irrigation is an essential component in the process of treatment whereby a chemically 
active solution is used during instrumentation of the root canal space. Irrigation is one 
of the most crucial steps of canal preparation because it helps to clean those areas of 
the root canal system that are not directly planed by instruments. 
 
The primary functions of an irrigant are:37 
1. Lubrication 
2. Flushing out of gross debris 
3. Dissolution of organic and inorganic material 
4. Antimicrobial 
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There are several irrigants used for intra-canal irrigation in root canal treatment. 
Chlorhexidene digluconate has been shown to produce sterility, improved clinical 
relief of symptoms, and reduced size of peri-apical lesions.38 The efficacy of 
chlorhexidene and sodium hypochlorite as antibacterial agents has been shown to be 
similar.39 The most commonly used and effective irrigant appears to be sodium 
hypochlorite solution (NaOCL). It is used in concentrations from 0.5 to 25%.40 It has 
a strong bactericidal effect and is known to be an irritant to vital tissue, but if used 
correctly does not cause damage or interferes with wound healing. As an endodontic 
irrigant it has been shown to increase and improve the bonding of resin cement to 
radicular dentine.41 It is also known to dissolve organic matter such as pulp tissue, 
bacterial tissue, necrotic pulp and bacterial products.42  However, this method in itself 
cannot render canals bacteria free, as even at high concentrations it has been shown 
that nearly one-third of root canals remained infected after instrumentation and 
irrigation with NaOCL.43 Thus it is recommended that an intra-canal medication 
between visits should be used to attain this goal.41 The rationale for the use of inter-
visit intra-canal medicaments is to destroy residual microorganisms and their toxins as 
well as to remove organic tissue. 
 
Ideally a medicament should have the following properties: 37 
1. Destroy all root canal microorganisms 
2. Have a lasting antimicrobial effect 
3. Be unaffected by organic material 
4. Help to remove residual organic tissue 
5. Penetrate the root canal system and dentinal tubules 
6. Not irritate periradicular tissues or have systemic toxicity 
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7. Have anodyne properties 
8. Induce a calcific barrier at the junction with periradicular tissues: 
9. Have no effect on the physical properties of the temporary filling 
material 
10. Not diffuse through the temporary filling material 
11. Be easily placed and removed 
12. Be radio-opaque 
13. Not stain the tooth.  
 
The most common inter-treatment medication is calcium hydroxide, which has 
antimicrobial effects through the release of hydroxyl ions. Calcium hydroxide has 
been shown to dissolve necrotic tissue and enhance the tissue dissolving effects of 
sodium hypochlorite solution.44 It has been shown to be effective against most root 
canal pathogens 44 and one study showed that large periapical lesions responded 
favourably enough to eliminate the need for surgical treatment.46 Another study found 
that infected root canals treated with calcium hydroxide were successfully disinfected 
in 97% of the cases 45 and this effectiveness was confirmed when the medicament 
was retained in the root canal for only one week.46 However, no bacteria-free root 
canals were recorded in another study, after placing calcium hydroxide for four 
weeks. However, the study had a small sample size, overestimated the effects of the 
inter-treatment medication over longer periods and used questionable sample 
techniques.47,48 
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 1.5.4 Obturation 
 
Obturation aims to prevent recontamination of the root canal. There are numerous 
techniques for obturation but there is insufficient evidence to support any particular 
one. The latest thermoplastic, resin-based sealer on the market is EndoRez (Ultradent, 
South Jordan, USA). The constituents of this material are hydrophilic and it is 
hypothesized 49 that the gutta percha would expand in the presence of humidity and 
thus reduces any voids, to produce an enhanced seal. This material was found to be 
most effective in sealing dentine when cured by fiber optic light.50 However, the 
sealing ability of EndoRez has been questioned 50 as it exhibited the largest amount of 
leakage when compared with gutta percha. In another study 51 a possible reason for 
this leakage was thought to be the interface between the sealer and dentine. SEM 
views indicated that the sealer produced a sponge-like appearance at the dentine 
interface, suggesting that the sealer was porous and allowed leakage to occur. Further 
research is clearly required to assess the effectiveness of EndoRez as a root canal 
sealer. 
 
The ideal root filling material should exhibit the following properties: 3  7
1. It must be antimicrobial 
2. It must not irritate periapical tissues but promote periapical healing 
3. It must possess no systemic toxicity 
4. It must have good flow characteristics 
5. It must adapt well to canal walls, to the extent of being adhesive 
6. It must exhibit no dimensional changes after placement 
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7. It must not be susceptible to disintegration by moisture and tissue fluid 
8 It must be radio-opaque 
9. It must have good manipulative characteristics and must be easy and 
quick to place 
10. It must be easy to remove for post-space preparation and re-treatment 
if necessary 
11. It must not stain dentine 
12. It must be cost effective  
 
1.6 Outcomes (Table 1.5) 
 
Endodontic outcome is a multifactor phenomenon.52 The success of a given therapy 
has been defined as “the result obtained which achieved the initial treatment goal”, 
and failure “a treatment that did not reach the objective or fell short of the acceptance 
level”. 7The success or failure of endodontic treatment is generally thought to depend 
on several factors: root morphology, experience of the operator, asepsis, intracanal 
procedures, bacterial culturing, interpretation of radiographs, materials and techniques 
used, and the position of the tooth. Other factors contributing to success are periapical 
pathosis, the level of working length relative to the radiographic apex, and the density 
of obturation.6 Chugal et al included preoperative pulp diagnosis, periapical diagnosis, 
the preoperative periapical radiolucency size, and the sex of the patient as factors 
contributing to endodontic treatment outcome.53 A major biologic factor influencing 
the outcome is the extent of microbiological insult to the pulp and periapical tissue.54 
Recent advances in endodontics such as the introduction of rotary instruments have 
substantially increased the success rates. Furthermore studies indicate that when 
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calcium hydroxide is used as an intracanal medication over a two-visit treatment, the 
success rate of the treatment procedure is far superior to the one-visit treatment.55 
Another study has claimed that endodontic treatment is a predictable procedure with a 
high incidence of tooth retention and with the least significant number of problems.51 
 
Although endodontists deal with a higher proportion of difficult cases and a smaller 
proportion of anterior teeth as compared with general dental practitioners, both groups 
of providers are noted to have comparable success rates.56 Statistically endodontic 
procedures in anterior teeth are more successful than posterior teeth.57 There was no 
proven difference in the success rate of endodontic treatment based on gender, 
position of the tooth in the arch or experience of the practitioner. 57 
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Table 1.5: Factors affecting the outcome of endodontic treatment 
FACTORS OUTCOME SOURCE 
1. MORPHOLOGY OF ROOTS 
1. STRAIGHT ROOTS 
2. CURVED ROOTS 
 
SUCCESSFUL   
DIFFICULT – NOT ALWAYS SUCCESSFUL 
Ingle et al, 2002
 52 
2. EXPERIENCE OF OPERATOR MORE EXPERIENCE = BETTER  OUTCOME 
Salehrabi, 2004
 50 
3. ASEPSIS ASEPTIC CANAL = BETTER OUTCOME 
Salehrabi, 2004
 50 
4. INTRACANAL PROCEDURES ROTARY = BETTER OUTCOME 
Salehrabi, 2004
 50 
5. POSITION OF TOOTH EASY ACCESS ALLOWS BETTER VISIBILITY = BETTER  OUTCOME 
Salehrabi, 2004
 50 
6. INTERPRETATION OF      
RADIOGRAPHS 
CLEAR INTERPRETATION OF RADIOGRAPHS = GOOD DIAGNOSIS 
= BETTER OUTCOME Chugal et al, 2001
 51 
7. BACTERIAL CULTURES 
ALLOWS THE OPERATOR TO ESTABLISH PROPER USE OF 
MATERIALS TO ERADICATE THE BACTERIA Chugal et al, 2001
 51 
8.WORKING LENGTH PROPER AND ACCURATE WORKING LENGTH = BETTER OUTCOME 
Salehrabi et al, 2004
 50 
9. OBTURATION GOOD TECHNIQUE = BETTER OUTCOME 
Walton, et al, 2002
 53 
10. SEX OF PATIENT FEMALES = BETTER OUTCOME 
Chugal et al,  2001
 51 
11. PERIAPICAL RADIOLUCENCY 
SIZE 
LARGER PERIAPICAL RADIOLUCENCY SIZE = POORER OUTCOME 
Chugal et al, 2001
 51 
12. PERIAPICAL DIAGNOSIS ACCURACY IN DIAGNOSIS = BETTER OUTCOME 
Chugal et al, 2001
 51 
 
The validity of these data is uncertain because there are no confirmatory studies, nor 
reviews to substantiate them. This generally seems to be the problem with research 
within the scope of endodontics.  
 
It seems self-evident that a high rate of quality outcome will be achieved from 
minimizing the variables that affect case adversity and by prescribing a level of 
treatment that is necessary to achieve success and to attain that level on a consistent 
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basis.58 A completed root canal treatment should be assessed by using a proper 
integration of clinical and radiographic factors.59 A longitudinal study of endodontic 
therapy, from 1956 to 2004, reported a success rate based on proper integration of 
clinical and radiographic features. The authors opined that concerns of failure 
regarding the need to do endodontic procedures are misguided and unsupported and 
that endodontic treatment should be preferred over tooth extraction and replacement 
procedures, including implants.57 However this study has never been reviewed and 
therefore cannot be substantiated. Furthermore the clinical aspect of the study was not 
standardized due to varied operators. This raises serious doubt about the conclusions. 
 
As with any other disease of infectious aetiology, prevention and treatment must be 
based on elimination of the etiological factor. Thus it must be reiterated, that proper 
shaping and irrigation is the basis of success in endodontic treatment. If the basic 
principles of endodontics are obeyed and observed, success can be assured in the 
majority of cases. 
 
1.7 Restoration of the endodontically treated tooth 
 
1.7.1 Introduction 
 
Despite the historical success of endodontic treatment, a critical aspect affecting that 
success is the sealing of the root canal, which also affects the future functions of the 
tooth. Clearly, restorations that may introduce leakage will put the tooth at risk.  
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There is a multitude of different materials available as coronal restorations yet there is 
no agreement on how best to close the chamber. 
 
1.7.2 Temporary Restoration 
 
The lack of a coronal seal is an important factor in the development of periradicular 
lesions following root canal therapy. Several studies have investigated how long it 
takes coronal leakage to adversely affect root canal treatment once a restoration has 
been lost. One study reported that leakage occurred within three days after loss of the 
coronal restoration; 60another indicated that it took 19 days for more than fifty percent 
of root canals to be contaminated and deemed a failure once the permanent coronal 
seal was missing.61 The presence of a temporary restoration, such as zinc oxide 
eugenol, may retard the process of coronal leakage, but this protection was only 
temporary for a period up to 27 days after placement of this temporary seal.62 
Inadequate root canal and coronal restorations have been associated with an increased 
incidence of apical periodontitis.63 It has been suggested that a permanent restoration 
should be placed in the most coronal portion of the access opening if there is 
perceived to be an extended period between completion of the root canal treatment 
and final restoration.63  
 
With proper temporization and timely placement of the final restoration, the potential 
for coronal microleakage will be minimized.64 A survey of practitioners found that 
most practitioners had a sound understanding of the principles involved in the 
restoration of endodontically treated teeth, with the possible exception of the length of 
time needed to establish a durable coronal seal after the placement of a root filling.6  1
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1.7.3 Permanent Restorations 
 
The quality of strength and durability of the coronal restoration determines the 
outcome of the endodontic procedure.1 It has been found that composite restorations 
on posterior teeth were associated with more pulpal breakdown than amalgams.65 An 
in vitro study found that glass ionomer and resin-modified glass ionomer restorative 
materials provided a better coronal seal against Streptococcus mutans than zinc 
oxide/eugenol in endodontic access cavities.56 Another study found significantly more 
dye leakage in teeth restored with compomer compared with those filled with a resin 
modified ionomer.66 
 
Posts are frequently used for the retention of coronal restorations. These can be 
custom-made or prefabricated. Few authors have investigated the coronal seal 
afforded by various post systems. Several new aesthetic post systems are available, 
but little is known about how effectively these posts seal the restored teeth. One study 
found that the resin-supported polyethylene fiber posts and glass fiber posts tested 
exhibited less microleakage compared with zirconia post systems. The latter system 
has exhibited a high level of leakage.67 Another study found that roots restored with   
a cast post showed very little, if any, microleakage as compared with metal 
prefabricated posts which demonstrated the most microleakage.68 This study further 
showed that the dentine-bonding cements have less microleakage than the traditional, 
non-dentine-bonding cements and concluded that adaptation of the post within the 
canal may be more important than the cement used.66 
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It has been suggested that to prevent re-infection of the root canal system, it may be 
preferable to restore the tooth immediately with a prefabricated post and composite 
system rather than place a temporary post crown and subsequently a cast post and 
core.69 However the small sample size of this study makes this conclusion 
questionable. A longitudinal study reported a high variability in seal quality among all 
types of posts and cores studied and suggested that permanent cementation of the post 
with the coronal restoration should be carried out as soon as possible to prevent 
recontamination of the root canal.70 Because neither the remaining root canal filling 
nor the post and core may be trusted alone for a seal, each should be performed with 
the greatest care and both covered with a crown as soon as possible.71 
 
The root canal filling remaining after post space preparation is commonly expected to 
provide adequate seal. One study suggested that 3 to 6 mm remaining after post space 
preparation provided a coronal seal inferior to that of intact root canal fillings.72  
 
1.7.4 Systemic Illnesses 
 
Other conditions, such as systemic illnesses are assumed to further influence the 
outcomes of endodontic treatment. One such condition that has devastating effects on 
the oral environment is HIV. The oral manifestations of this condition are well 
researched yet there is very little, if any, knowledge on the interplay between 
endodontic presentation, procedural outcomes, and HIV.  
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CHAPTER 2: MEDICAL CONDITIONS AND MEDICAL TREATMENT 
REGIMES AFFECTING THE NEED FOR ENDODONTIC TREATMENT AS 
WELL AS THE OUTCOMES OF ENDODONTIC THERAPY 
 
Systemic conditions such as cardiovascular diseases, diabetes, organ transplants, acute 
and chronic leukaemias, and HIV pose a direct challenge to endodontic therapy. The 
treatment of periapical lesions of various severities may cause negative reactions in 
such patients who may therefore require special adjustments and precautions during 
their endodontic procedures. 
 
2.1 Cardiovascular disease 
 
It is recommended that patients with ischaemic heart disease be treated in the dental 
chair using short appointments, using local analgesia, which may imply that 
endodontic treatment should preferably be done in one visit. Invasive dental 
procedures for patients who have had a myocardial infarct within the last six months 
should be deferred for three to twelve months. 73 Pulp testers should not be used 
during endodontic therapy in patients with cardiac pacemakers, as the pulp tester may 
interfere with the function of the pacemaker. The risk is small but nonetheless must be 
avoided.74  
 
Whilst some studies have reported that endodontic treatment in patients with cardiac 
valvular defects can produce a bacteraemia which could lead to infective 
endocarditis,75 others have shown no detectable bacteraemia following non-surgical 
endodontic procedures.74 Reaming, filing and filling of the root canal seems to be 
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relatively safe.74 Nonetheless the American Academy of Paediatric Dentistry  
recommend the use of appropriate prophylaxis prior to endodontic therapy in order to 
negate all possible risks.76  
 
There is also a weak link concerning the relationship between the presence of 
endodontically treated teeth with periapical destruction and coronary heart disease, 
implied from a correlation found between coronary heart disease and oral infections in 
a longitudinal study of 447 patients.77 
 
Pulp tissue samples obtained from patients with cardiovascular disease, showed 
vascular changes followed by reactional responses such as acute and chronic 
inflammatory changes, atropic and dystrophic changes, and dysphasia, all indicative 
of the need for endodontic therapy.78 However this study had no control group and 
therefore no comparison could be made with patients who did not have cardiovascular 
disease. 
 
Anatomical studies by Gafar indicate that cardiovascular and diabetic pulpal changes 
follow the same sequence of events.7  7
 
2.2 Diabetes 
 
2.2.1 Introduction 
 
Diabetes has been described as a complex disease with metabolic and vascular 
components.79 The metabolic component involves “the elevation of blood glucose 
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associated with alterations in lipid protein metabolism resulting from a relative or 
absolute lack of insulin”. The vascular component includes an “accelerated onset of 
non-specific atherosclerosis and a more specific microangiopathy that particularly 
affects the eyes and kidneys”.79 Fouad and Burlenson aptly summarised diabetes as “a 
chronic disease with serious health consequences”.80 
 
2.2.2 Endodontic treatment and diabetes 
 
A recent review on diabetes and the dental pulp and endodontic treatment of patients 
with diabetes indicated that: 81 
 
1. There was a greater prevalence of peri-apical lesions in type 1 diabetics 
2. The pulp tissue of diabetic patients may react differently from non-
diabetics 
3. The evidence indicated a reaffirmation of the condition referred to as 
“diabetic odontalgia”  
4. There were trends toward increased symptomatic periradicular disease 
in diabetic patients who receive insulin 
5. There were increased pre-operative and post-operative endodontic 
flare-ups in controlled diabetic patients. 
 
The altered reaction of diabetic patients to pulpal problems may be the result of their 
being particularly prone to bacterial and opportunistic infections due to circulatory 
disorders.81  
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There appear to be differences in the natural history of endodontic infections in 
diabetic patients, with a significantly higher proportion of clinically severe pulpal or 
periodontal infections being observed.82 There has been an association reported 
between the presence of diabetes and increased numbers of certain pathogenic micro- 
organisms in root canals.82 The number of organisms of P.endodontalis and 
P.gingivalis was positively higher in diabetic patients as compared with nondiabetics. 
E.faecalis has been found to be the most prominent organism in nonhealing cases.80 
Furthermore; studies suggest that the type 1 diabetic host with no glycaemic control 
may experience an increase in periapical lesion size.83 The results also showed that 
diabetics with preoperative periapical lesions had a significantly lower chance of 
success compared with non-diabetic individuals. Thus differences in the pathogenesis, 
progression, and healing of pulpal and periradicular pathosis in diabetics do exist. 
 
Evidence based guidelines on antibiotic prophylaxis classify diabetes as a condition 
with compromised immunity, and therefore prophylactic antibiotics are advocated.75  
There was an increased risk of endodontically involved teeth showing periradular 
lesions but no caries, in patients with a compromised immune response, implying that 
a retrograde infection actually caused an endodontic response.84 Diabetes mellitus and 
heart disease may predispose the host to endodontic infections in teeth that show no 
signs of caries.76, 81Endodontic infections in diabetic patients showed a more virulent 
microbial profile, with Eubacterium spp being the most prevalent, 83indicating that the 
virulent microbial profile could possibly be the cause of the endodontic response. 
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2.3 Organ transplants 
 
Patients with organ transplants are known to present with a high rate of infectious 
complications, with patients receiving renal transplants being at least risk. There is 
little evidence that dental disease contributes to this risk.7  8
 
Post-transplant infection by bacteria, viruses, or fungal organisms is the most common 
cause of mortality in the immunosuppressed recipient of an organ transplant. Thus it 
is recommended to eradicate and avoid the spread of any possible infection in the 
body. As such the dental practitioner who is confronted with endodontic infections 
must eliminate the potential sources of infection. Prophylactic antibiotics are highly 
recommended.85 
 
2.4 The irradiated patient 
 
The infected and inflamed periodontium can act as a focus of systemic infection 
especially in cancer patients. Periodontal infections can be easily overlooked because 
the symptoms of gingival inflammation may be minimal and the infection may be 
located in deeper parts of the periodontium.86 
 
Endodontics and periodontics are the primary treatments of choice for the elimination 
of infections that threaten osteoradionecrosis in patients receiving cancercidal doses 
of radiation therapy for head and neck cancer. Changes have been noted in the 
mucosa, taste buds, salivary glands, bone, periodontium, teeth, oral flora, and muscles 
of mastication.78  Endodontic treatment is performed in order to avoid extractions or to 
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postpone such treatment to a less threatening post irradiated period. Antibiotic cover 
of 500mg of penicillin, four times daily, for the entire course of endodontic treatment 
has been advocated.86 The same authors opined that the tooth must never be left open 
for drainage in the irradiated patient and extreme care must be taken with the 
between-visits seal.8  6
7
 
Shorter lengths during instrumentation of the root canal are preferred over extended 
lengths so as to prevent periapical trauma. An ideal and safe working length is 0.5mm 
to 1mm short of the radiographic apex. An interesting but unsubstantiated finding 
went so far as to advocate that after caries debridement and endodontic therapy has 
been performed, the crown should be amputated at or below the gingival level and the 
canal should be filled with amalgam to prevent the risk of coronal leakage leading to 
periapical failure.85 However this recommendation can be the cause of many other 
problems within the oral environment. In primary teeth, obturation with calcium 
hydroxide appears to be the treatment of choice.87 
 
Only one study has reported on the longitudinal outcomes of endodontic therapy in an 
irradiated patient with leukaemia.88 No osteoradionecrosis was seen in association 
with endodontically treated teeth over 54 months.89 However, Gafar suggested that in 
leukaemic irradiated patients, endodontic treatment should be contraindicated because 
the inflammatory reactions and dystrophic changes in the pulpal tissue presented as 
degenerative lesions, probably because the invasive manifestation of the leukaemic 
process is more intense.7  
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2.5 Von Willebrand’s disease 
 
This is the most common inherited bleeding disorder in humans. It changes the 
platelets’ physiology, thereby preventing platelet adhesion, which is required during 
the clotting process. It affects factor 8 of the “cascading clotting tree”.78 
Camm and Murata advocated the use of cryoprecipitate for all invasive dental 
procedures in order to prevent excessive bleeding. For this reason it was suggested 
that root canal procedures be performed as a single visit treatment.90 
 
2.6 Rheumatoid arthritis 
 
Rheumatoid disease is a chronic systemic illness. It is a common autoimmune disease 
of unknown aetiology. 
 
Recent modern laboratory techniques, such as polymerase chain reaction (PCR) have 
helped to identify micro-organisms from the root canal in patients with arthritis. 
According to one review, chronic latent periradicular lesions may stimulate arthritic 
inflammation, because the same micro-organisms were found in both the periradicular 
and arthritic sites. A more convincing association was that the immunological and 
histological reaction occurring in the periradicular lesion was similar to the 
inflammatory reaction occurring in rheumatoid arthritis. IgG rheumatoid factor was 
found to be present in the periapical tissues of rheumatoid sufferers.91 
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2.7 HIV 
 
The human immunodeficiency virus is predominantly transmitted via body fluids and 
this in itself calls for precautionary measures by the dental team. It is known that 
people who are HIV positive suffer from a variety of oral lesions and that these 
patients have a much higher level of dental and gingival disease.92 Therefore, it may 
be logical to assume that endodontic infections in the HIV group would present with 
an exaggerated response. 
 
Although a study reported HIV in the dental pulps of patients with AIDS, 92 a 
systematic review in 2002 found little to no complications in HIV positive patients 
receiving routine endodontic treatment, 93 and suggested that the evidence at that time 
was insufficient with respect to risks associated with root canal procedures in HIV 
positive patients. It was therefore suggested that HIV patients requiring dental 
treatment should be treated as for any other patient.93 However, it is important to 
remember that the condition presents at different stages with increasing systemic 
manifestations and complications. This means that the difference in the treatment 
regime would be the need to modify treatment according to the presenting clinical 
finding or underlying systemic condition. Haematological abnormalities are relatively 
common with HIV infection because of the HIV disease process or as a consequence 
of antiretroviral drug therapy.94,95 Lowering of the CD4 count was shown to increase 
the severity of haemostatic abnormalities, but this risk is most unlikely during routine 
non-invasive endodontics.9  3
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A study on felines induced with the immuno-deficiency virus resulted in an increased 
prevalence of peri-apical pathosis in subjects with lowered CD4 cell counts.96 
 
Because HIV is an immuno-suppressive disorder, a short-term study recommended 
that root canal treatment of patients who are HIV positive be performed as a one-stage 
treatment procedure with antibiotic cover, and that root canal treatment to molars be 
avoided due to a generally poor prognosis.97 Other authors have recommended that 
root canal procedures for patients who are HIV positive be avoided entirely and 
instead extraction or surgical endodontics of teeth requiring root canal procedures be 
carried out.98 But there has also been a recommendation that root canal treatment on 
HIV positive patients could be carried out following standard procedures and without 
antibiotics. 99 However this study was a cross-sectional horizontal study which 
ignored important variables such as CD4 counts, viral loads, and antiretroviral 
erapy. 
rstanding of this chronic disease, which is 
therefore summarized in the next chapter.  
th
 
With the increase in the number of HIV positive patients visiting dentists for routine 
and endodontic treatment, especially young patients, the need to study the reaction of 
HIV patients to endodontic infections and treatment becomes essential and all 
practitioners should have a thorough unde
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CHAPTER 3: HIV 
 
The HI virus causes a chronic, long-term debilitating illness, with no known cure. It 
has impacted on the world with suddenness and has sequelae of serious health, social 
and economic consequences.  
 
3.1 Epidemiology 
 
According to recent estimates from the Joint United Nations Programme on AIDS 
(UNAIDS), 37.8 million people world-wide were living with HIV/AIDS in 2003.100 
Of these 5.3 million were South Africans, including 230 000 children under the age of 
15.101 There are clear indications that South Africa has the highest number of people 
living with HIV/AIDS in the world. The mortality number caused by HIV/AIDS in 
South Africa, was estimated to have been 370 000 lives in 2003. This was more than 
1000 people per day.1  00
 
The impact of the epidemic on population size is illustrated in figure 3.1, which 
estimates the projected population size in South Africa, with and without the AIDS 
epidemic. The figure shows a dramatic decrease in population in 20 years’ time, 
especially in the 40-70 yrs age group, and especially the females in this group.100 
  
This devastating epidemic has grave social and economic repercussions for South 
African society. 
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Figure 3.1- The hypothetical size of the South African population with and without 
AIDS (UNAIDS, 2004 Report on the global AIDS epidemic, 4th global report)100 
(used with permission). 
 
3.2 Origins and history of the epidemic 
 
There are two species of the human immunodeficiency virus, HIV-1 and HIV-2, but 
their origins are unknown. There are 3 main theories:  
 
It is assumed that both these species arose in Africa as zoonotic infections from 
primate hosts. 102 These hosts have their own unique lentiviruses known as simian 
immunodeficiency virus (SIV). SIV is spread sexually amongst primates, but the 
primates themselves do not develop immunodeficiency. HIV-1 arose in Central Africa 
from the closely related chimpanzee lentivirus whilst HIV-2 was acquired in West 
Africa from the Sooty Mangabey monkey. It is thought that humans became infected 
when slaughtering primates for bush meat trade. According to Hunt, risk of infection 
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comes not so much from eating the meat but rather from the process of slaughtering 
the animal.10  2
 
Another possible origin of HIV is referred to as the CHAT theory. This theory refers 
to the late 1950s when a virologist called Hiliary Koprowski, created a polio vaccine 
called CHAT. The hypothesis is that he used monkey kidneys to grow the poliovirus 
needed to make the vaccine, and the HI virus leapt the species barrier to humans. This 
theory is supported by evidence that early cases of the HIV disease were closely 
correlated with places where the vaccine trials had been carried out.103,104 
 
It has also been speculated that HIV was created by the American Central Intelligence 
Agency as a means of biological warfare. It was allegedly to be used for Black 
African and homosexual American genocide and Dr Robert Gallo, the person who 
discovered the HIV virus, was reported to be linked to a biological weapons project 
called MKNAOMI. This project was allegedly used to produce AIDS-like viruses in 
the 1970s. These allegations are based on the fact that the director of national security, 
Henry Kissinger, during the time of President Nixon’s regime, was responsible for the 
MKNAOMI project. 105 
 
HIV was first isolated in 1983. The first populations to be affected were: 
1. Men and women with multiple sex partners in East and Central Africa 
2. Men who have sex with men (MSM) in some urban areas of Western 
Europe, America and Australia. 106 
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3.3 Characteristics of HIV epidemics according to region  
 
3.3.1 Sub-Saharan Africa 
 
This is the most highly affected region, comprising 70% of the total HIV +ve 
population globally, with Botswana having the highest rate of infection in the world. 
The predominant mode of transmission is heterosexually;107 the second commonest 
mode is mother-to-child.108 Infection levels in women are higher than in men. A study 
indicated that 12 to 13 African women are infected for every 10 African men.108 
 
3.3.2 Asia and the Pacific 
 
Asia has over 16% of HIV +ve individuals globally. The predominant mode of 
transmission is heterosexually, with intravenous drug use also playing a significant 
role.109 
 
3.3.3 North America, Western Europe, Australia 
 
Initially the HIV infection mainly affected the gay, MSM population, before 
spreading to women and children, minority groups and the disadvantaged. Recent 
trends have shown increased transmission through heterosexual and intravenous drug 
use (IVDU).1  07
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3.3.4 Eastern Europe and Central Asia 
 
This area experienced the fastest growing HIV epidemic in recent times with IVDU 
being the most common mode of transmission.10  7
08
 
3.3.5 Latin America and the Caribbean 
 
The main mode of transmission is heterosexual. IVDU and homosexuals also play a 
significant role.107 
 
3.3.6 North Africa and the Middle East 
 
The HIV rate in this area is currently very low. There are a few known cases and the 
predominant mode of transmission is IVDU. 108 
 
3.4 Distribution of HIV types and subtypes 
 
HIV-1 has three groups of isolates termed: 
1. M (major) 
2. N (non-M, non-O) 
3. O (outliers) 
 
The majority of HIV-1 infections are caused by the M type virus. The M group is 
further divided into 10 genotypes, A to J. The predominant genotype in South Africa 
is HIV-1 subtype C.1  
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HIV-2 was first discovered in 1986 from AIDS patients in West Africa. 101 HIV-2 has 
five genotypes, A to E. 
 
3.5 Basic patho-physiology 
 
The HI virus is the virus that causes AIDS. HIV invades CD4 cells, reproduces within 
them, and then bursts out into the bloodstream, thereby destroying the CD4 cells. The 
body responds by producing more CD4 cells to ward off the infection. This immune 
response is ineffective because the replication of the HI virus far exceeds that of the 
CD4 cells, and ultimately destroys them. The cycle continues until the immune 
system eventually stops functioning, leaving the body defenseless against other 
infections.110 This results in full-blown AIDS. 
 
3.6 HIV in South Africa 
 
The AIDS epidemic is one of the greatest challenges facing South Africa. It is a 
dynamic epidemic, which defies all barriers and exploits new opportunities for 
transmission. The most highly affected region in the world is Southern Africa. There 
is no single factor, biological or behavioral, which determines the spread of this 
infection.  
 
The first two cases of AIDS were identified in South Africa in 1982. By 1999 about 
one-in-nine South Africans (or five million people) are living with HIV/AIDS.111 
Two-thirds of the South African youth are living with the disease, between the ages of 
15-25years.11  1
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South Africa, as a nation, is highly vulnerable to the impact of AIDS. It has had a 
devastating effect on social, economic, and, above all, human development. Factors 
such as the legacy of apartheid with poverty, migrant labour systems, poor education 
and high levels of violence and rape, create a fertile environment for the rapid spread 
of HIV. Coovadia and Hadingham108 argued that as long as poverty cannot be 
controlled, the HIV epidemic will remain a pandemic in South Africa. They further 
commented that women in South Africa are at greater risk of infection due to cultural 
mores and an increase in domestic violence and rape. They estimated that one in four 
women are victims of rape or domestic violence. 
 
Figure 3.2 demonstrates the vicious cycle of effects that HIV has on families, from a 
social and economic standpoint.98 Emotional and financial burdens on AIDS orphans, 
make these children more vulnerable, increasing their susceptibility to the disease. 
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Figure 3.2: The vicious cycle amongst families and children affected by HIV and 
AIDS – UNAIDS, 2004 Report on the global AIDS epidemic98 (used with 
permission) 
 
3.7 WHO staging systems 
 
Staging aims to make guidelines for clinical decision making for the management of 
HIV/AIDS patients. There are several classifications and staging systems for HIV, but 
the most commonly accepted are the Centres for Disease Control and Prevention 
(CDC) and the World Health Organization (WHO) classifications. 
 
The CDC classification109 is based on immunological parameters (CD4 counts), 
clinical parameters and virological parameters and requires laboratory confirmation of 
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many clinical events. This classification is widely used in industrialized countries that 
have adequate resources to support the various expensive tests required. 
 
In developing countries, the required technology may not be available or may be too 
expensive to support the CDC classification system. The WHO has proposed a 
simplified staging system that is clinically based and flexible enough to be used in 
various parts of the world.110 The WHO staging system has been proposed for use in 
Africa because of limited resources as well as the need for health workers at all levels 
to have the necessary knowledge to decide on the most appropriate patient care and 
support. The system is based on four groups of clinical conditions that are considered 
to have prognostic significance and therefore constitute stages. The clinical staging 
presented in table 3.1, is to be used for those who are 15 years and above and for 
whom there is confirmed laboratory evidence of HIV infection. A separate table is 
available for staging in children.110 
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Table 3.1: Revised 2005 WHO clinical staging of HIV/AIDS for adults and 
adolescents110 
Primary HIV infection 
 Asymptomatic 
 Acute retroviral syndrome 
Clinical stage 1 
 Asymptomatic 
 Persistent generalized lymphadenopathy 
(PGL) 
Clinical stage 2 
 Moderate unexplained weight loss 
 Recurrent respiratory tract infections 
 Herpes zoster 
 Angular cheilitis 
 Recurrent oral ulcerations 
 Popular puritic eruptions 
 Seborrhoeic dermatitis 
 Fungal nail infections of fingers 
Clinical stage 3  
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations 
 Severe weight loss 
 Unexplained chronic diarrhea for longer than one month 
 Unexplained persistent fever (intermittent or consistent for longer than one month) 
 Oral candidiasis 
 Oral hairy leukoplakia 
 Pulmonary tuberculosis diagnosed in the last two years 
 Severe presumed bacterial infections 
 Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
Conditions where confirmatory diagnostic testing is necessary: 
 Unexplained anemia and/or neutropenia and/or thrombocytopenia 
 Extra pulmonary cryptococcosis including meningitis 
 Disseminated non-tuberculosis mycobacteria infection 
 Progressive multifocal leukoencephalopathy 
 Candida of the trachea, bronchi or lungs 
 Isosporiasis 
 Visceral herpes simplex infection                                             
 Lymphoma 
 Visceral leishmaniasis 
 Cryptosporidiosis 
 Cytomegalovirus infection                                                          
 Invasive cervical carcinoma                                                       
 Any disseminated mycosis 
 Recurrent non-typhoidal salmonella septicemia 
Clinical stage 4 
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations 
 HIV wasting syndrome                                                                             
 Central nervous system toxoplasmosis                                                   
 Oesophageal candidiasis 
 Kaposi’s sarcoma 
 Extrapulmonary TB 
 Pneumocystis pneumonia 
 Recurrent severe or radiological bacterial pneumonia 
 Chronic herpes simplex infection (for more than one month) 
 HIV encephalopathy 
 
The WHO states: 
 
“For clinical management purposes this staging system is designed to be used: 
1. as an assessment guide on when to start intervention therapy 
when to switch or stop ART 
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2. to assess current clinical status of individuals receiving HIV care, 
either on or off ART 
3. encourage diagnostic testing 
4. to guide clinicians in assessing the response to intervention therapy, 
especially where CD4 and viral load measurements are not easily 
available. 
 
For surveillance purposes this staging system is designed to: 
1. classify disease from least to most severe 
2. be used with reference to current clinical events 
3. be used in relation to previous clinical events.”110 
 
3.8 Oral manifestations 
 
Oral manifestations of HIV infection are a fundamental component of disease 
progression and estimates of occurrence varying between 30 and 80 percent of the 
infected population.111,112 Factors which predispose expression of oral lesions include 
CD4 counts, viral loads, xerostomia, poor oral hygiene and smoking. Oral lesions are 
differentiated into fungal lesions, viral lesions, bacterial infections, neoplasms such as 
Kaposi’s sarcoma, and non-specific presentations such as aphthous ulcerations and 
salivary gland disease.113 
 
Many initial clinical signs of HIV infection and AIDS occur in the oral cavity and 
may serve as markers for early immune deterioration and disease progression. Intra-
oral manifestations can be recognized by clinical appearance, histological 
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characteristics, and causative pathogens. Their clinical appearance provides a 
presumptive diagnosis that in many instances is sufficient to initiate therapy.112 
However no studies thus far have managed to give exact numbers to the prevalence 
and incidence of oral manifestations.114 
 
The common intraoral manifestations associated with HIV disease are:1  12
 
Fungal infections:  Erythematous candidiasis, psuedomembranous candidiasis, 
hyperplastic candidiasis, angular cheilitis 
Viral infections: Herpes simplex virus, cytomegalovirus, oral hairy leukoplakia, 
human papilloma virus 
Bacterial infections: Necrotizing ulcerative gingivitis and periodontitis, linear 
gingival erythema, syphilis 
Neoplasms: Kaposi’s sarcoma, non-Hodgkin’s lymphoma, squamous cell 
carcinoma 
Miscellaneous: Hyper pigmentation, aphthous ulcer 
 
 
 
3.9 Antiretroviral therapy (ART) 
 
Antiretroviral therapy began in the late 1980s with the introduction of AZT (the 
nucleoside reverse transcriptase inhibitor zidovudine). The benefits of this drug were 
not long sustained due to the development of early resistance. In the early 1990s a 
combination therapy of the same class of drugs became available. The combination 
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therapy was shown to be much more effective than monotherapy. Even though dual 
therapy proved more beneficial, resistance against this combination also eventually 
developed.115 
 
In the mid 1990s protease inhibitors (PI) and the non-nucleoside reverse transcriptase 
inhibitors (NNRTIs) were introduced. With the combination of these drugs viral 
replication could be completely suppressed. When viral replication is suppressed 
mutations do not occur and resistance does not develop. Thus highly active 
antiretroviral therapy (HAART) could be used justifiably. Since the introduction of 
HAART the morbidity and mortality rates amongst HIV sufferers have declined 
considerably.116 
 
3.10 Prevention strategies 
 
Some current HIV prevention strategies include education and awareness, blood 
transfusions, prevention of mother to child transmission, condom use, behavior 
modification and prevention of IV drug use. Future strategies include the development 
of HIV vaccines.117  
 
The application of the ABC prevention approach to sexual behavior advocates 
delayed sexual debut for adolescents (A, abstinence), partner reduction (B, be 
faithful), and factual information regarding condom use (C, condoms). It has been 
successfully introduced in Uganda, a country previously experiencing significant HIV 
rates.117  
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3.11 Infection control 
 
The use of proper infection control precautions to protect against transmission of 
bloodborne and other occupational microbial pathogens has become a routine 
component of health care provision.118 Dental health care workers have a 10 times 
greater risk of becoming a chronic Hepatitis B carrier than the average citizen, but 
dentists remain at low risk for acquiring the HIV via dental treatment provisions.119 
Although it is believed that most patients report their medical histories to the 
practitioner to the best of their ability, it seems that many of these patients might not 
be aware that they carry transmissible diseases.120 HIV and tuberculosis are 
increasing at a significant rate and this creates serious concerns for the health care 
am. 
 control procedures helps to protect practitioners, 
atients and the community.122  
.12 Attitudes concerning dental care 
te
 
Despite the prevalence of so many serious diseases some studies have shown that not 
all dentists wear gloves routinely.121 The goal of infection control is to minimize the 
spread of potentially pathogenic micro-organisms and to remove or to kill organisms 
that have contaminated objects and surfaces.121 Emphasis must be placed on 
consistent adherence to the recommended infection control strategies, including the 
use of protective barriers and appropriate methods of sterilization or disinfection. The 
application of proper infection
p
 
3
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The attitudes of HIV patients in the USA, towards receiving dental care are generally 
quite positive. According to McCarthy, Haji and Mackie the majority of patients 
believed that they could trust their dentist with confidentiality, good and appropriate 
treatment, comfort of treatment and adequate knowledge to deal with the associated 
problems.123 Patients who have been refused treatment were usually those individuals 
from the lower socio-economic groups who could not afford to pay.124 Financial 
factors related to income and medical aid coverage have been found to limit access to, 
and i lunf ence use of, oral health care services by people with HIV. Many patients 
hange providers for the fear of rejection or the refusal or reluctance of a dentist to 
atio
his makes it imperative for clinicians to use their clinical judgement, to 
rovide dental care tailored to the individual circumstances of the HIV-positive 
c
treat.123 
 
In South Africa HIV positive patients who are unemployed have free access to 
government health care institutions for their treatment. According to the Health 
Professions Council of South Africa rejection for treatment on the basis of HIV 
infection is considered unethical.125 These dentists can be charged for discrimin n 
under the Charter of Human Rights. In South Africa research involving attitudes of 
HIV patients as well as attitudes of practitioners towards HIV patients is lacking.cxxviii  
It is evident that limited published scientific evidence is available to guide clinicians 
in regard to possible increased risks of invasive oral procedures associated with HIV 
status. T
p
patient.  
 
3.13 HIV and endodontics 
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Endodontics is an invasive procedure which is directly related to several systemic 
conditions.83 As in diabetes HIV positive patients are also similarly prone to 
opportunistic infections due to alterations in the immune system. However the 
lationship between HIV and endodontics remains unclear. This research proposes to 
investigate this relationship to assist in the plight of the HIV patient. 
 
re
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CHAPTER 4: AIMS AND OBJECTIVES 
 
4.1 Aim 
 
To compare the presenting symptoms and the outcomes of root canal therapy between 
HIV positive and HIV negative endodontic patients over a 6-12 month period. 
 
Null hypothesis 
 
There is no difference: 
1. in the presentation of pulp pathology between HIV infected patients and 
healthy (non-diabetic and non-HIV) controls; 
2. resources used to treat endodontic lesions between HIV infected patients and 
healthy (non-diabetic and non-HIV) controls; 
3. in the outcome of endodontic therapy between HIV infected patients and 
healthy (non-diabetic and non-HIV) controls; 
4. between presentation of pulpal pathology, and treatment outcome and CD4 
counts in HIV infected patients (non-diabetic)  
 
4.2 Objectives 
 
1. To compare the preoperative presentation of endodontic infections/conditions 
between HIV positive and negative patients, using clinical and radiographic 
criteria 
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2. To compare the presentation and outcomes of endodontic infections by HIV 
positive patients with their different CD4 counts  
3. To identify if pulpal pathophysiology of HIV infected patients is similar to 
that of other systemic conditions producing an immune-compromised state. 
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CHAPTER 5: MATERIALS AND METHODS 
 
5.1 Study design 
 
The study has been carried out at the Wits Dental Hospital at Johannesburg Academic 
Hospital. Patients were drawn from those referred to the dental HIV clinic from the 
surrounding clinics in the Johannesburg area, the Wits Dental Hospital emergency 
clinic, as well as the Wits medical HIV clinic. The Bioethics Committee has approved 
this study (R14/49) (Appendix 1). Informed consent was obtained from all patients 
(Appendix 2). 
 
This study was a prospective case-control clinical study. Consenting HIV infected and 
normal healthy controls who were diagnosed with pulpally involved teeth received 
endodontic treatment and were followed up at 6 months and 18 months post-
operatively. One dental assistant only who is also a qualified HIV counselor, assisted 
the operator. The assistant pre-counseled patients and they were subsequently tested 
for HIV. The assistant thereafter post-counseled patients based on the outcome of 
their HIV test results. This allowed for strict levels of confidentiality. A single 
operator carried out the required procedures on all patients. The operator was blinded 
to the HIV status of the patients.  
 
Calibration was done as a double-blind study. The original clinician and another 
independent clinician examined 20 randomly selected patient files from the study. 
Information according to the presenting clinical symptoms was taken into 
consideration and the clinicians noted the symptomatic outcomes in terms of 
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endodontically classifying the patient. These outcomes were recorded and statistically 
compared. 
 
As part of the calibration another 10 patients were selected from the emergency 
section of the Wits Dental Hospital. An independent clinician ensured that all 10 
patients were in need of endodontic treatment. Every patient was examined by the 
original clinician as well as the original independent clinician. Signs and symptoms 
were noted and then compared between the examiners. Once again the examinations 
were recorded and statistically compared. 
 
All patients were assessed according to evaluation procedures discussed below. Thus 
treatment for every patient was consistent within set protocols. 
 
5.2 Subject selection 
 
The study group comprised 46 HIV positive patients, and the control group comprised 
59 HIV-negative individuals. These groups were not matched according to gender. 
The age ranged between 25 to 50 years. At a probability level of 95% and a power 
level of 80% it was calculated that the sample size would need to be at least 45 in 
each group.  A decision was made to try to increase the number to 60 in each group in 
order to maintain adequate numbers and to allow for dropouts. Certified proof from 
laboratory tests to confirm their HIV negative status was obtained from all members 
of the control group. Furthermore, the operator, who once again took a finger prick 
test of all participants, with their verbal consent, reconfirmed their HIV status. All 
patients were asked for a doctors’ letter to confirm their diabetic status. All diabetic 
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patients were excluded from the study. Only those patients who indicated their 
willingness to be tested and to return for follow-up visits participated in the study. 
However all patients were given the dental care they required. 
 
CD4 counts were taken of all HIV positive patients to compare the response to 
endodontic infection and treatment outcome according to different CD4 counts. The 
CD4 results were obtained from the laboratory blood tests prior to commencement of 
the endodontic treatment, and again at 6-monthly intervals. 
 
5.3 Diagnostic evaluation: 
 
A questionnaire was designed to record personal demographic information, medical 
history, HIV status, and standard endodontic questions of symptoms which 
encompassed details on the severity and duration of any symptoms including pain, 
swelling, and sensitivity (Appendix 3). 
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5.4 Clinical examination: 
 
Clinical signs and symptoms including fever, lymphadenopathy, and malaise were 
noted. Full extra and intraoral examinations were performed. Extra-oral examination 
included signs and symptoms of jaundice, anemia, cyanosis, clubbing of the 
fingernails, lymphadenopathy, and oedema, as well as the presence of extra-oral 
swellings, asymmetry of the face, temporo-mandibular joint abnormalities, and 
abnormalities or discolouration of the lips and cheeks. Intraoral examination included 
the characteristics of swellings of various forms and sizes for example soft, hard, size, 
duration of swelling. It also included the examination of teeth for primary caries, 
restorations, secondary caries, fractures and mobility. A history of the signs and 
symptoms was also noted. 
 
Clinical endodontic tests included thermal tests, percussion, palpation, and 
radiographs. 
 
5.4.1 Thermal test 
 
This test was made with ethyl chloride as well as hot Gutta Percha on the tooth of 
concern. The tooth was isolated with a rubber dam in order to avoid false positives 
from adjacent teeth. On removal of the stimulus from the tooth any lingering quality 
of pain was taken as evidence of irreversible pulpitis. If pain subsided immediately 
after the stimulus was removed, reversible pulpitis was diagnosed. 
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5.4.2 Percussion 
 
Percussion provides information on the periodontal status of the tooth, whether 
inflamed and sensitive or normal and non-responsive. This was merely used to find 
the problem tooth.  Percussion involved gentle tapping with the end of a mirror 
handle, on the incisal/occlusal surface of several teeth in the area in question. 
Sometimes a tooth reacted with severe pain; however the final diagnosis required 
additional information gained from other tests. 
 
5.4.3 Palpation 
 
Sensitivity to finger pressure on the mucosa over the apex of a tooth, buccal or 
lingual, signaled the further spread of inflammation from the periodontal ligament to 
the periosteum overlying the bone. This examination was most effective when it was 
made bilaterally at the same time. 
 
5.5 Radiographic evaluation: 
 
Panalipse and full mouth radiographs were taken for assessment of each patient. The 
panalipse was taken to eliminate any cause of pain, other than an endodontically 
involved tooth. 
 
Full mouth radiographs were taken to detect peri-apical radiolucencies. These 
radiographs also helped to make a comparison between different teeth and what could 
be causing pain. The radiographic features of pulpitis are outlined in table 5.1. 
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 5.6 Post-operative radiographic evaluation 
 
A post-operative peri-apical radiograph was taken to assess the success or failure of 
the endodontic treatment rendered. Success of treatment was defined as elimination of 
signs and symptoms together with a decrease in the size of the peri-apical 
radiolucency. Failure of treatment was defined as continuing signs and symptoms 
together with no changes or exacerbated features radiographically. 
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Table 5.1: Radiographic stages of pulpitis 
STAGE OF INFLAMMATION 
UNDERLYING 
INFLAMMATORY 
CHANGES 
RADIOGRAPHIC 
APPEARANCES 
Initial acute inflammation 
Inflammatory exudate 
accumulates in the apical 
periodontal space (swelling) 
The tooth becomes tender (pain) 
The patient avoids biting on the 
tooth (loss of function) 
Widening of the radiolucent line 
of the periodontal ligament 
space 
Or 
No apparent changes 
Initial spread of inflammation Resorption and destruction of the apical bony socket 
Loss of the radiopaque line of 
the lamina dura at the apex 
Further spread of inflammation 
Further resorption and 
destruction of the apical alveolar 
bone 
Area of bone loss at the tooth 
apex 
Initial low-grade chronic 
inflammation 
Minimal destruction of the 
apical bone. 
The body’s defense systems lay 
down dense bone in the apical 
region 
No apparent bone destruction 
but dense sclerotic bone evident 
around the tooth apex 
Latter stages of chronic 
inflammation 
Apical bone is resorbed and 
destroyed. 
The body’s defense systems try 
to confine the spread of 
infection by laying down dense 
bone around the area of 
resorption. 
Both processes are occurring 
simultaneously 
Circumscribed, well defined 
radiolucent area of bone loss at 
the apex. 
Surrounded by sclerotic bone- 
periapical granuloma or cyst 
 
5.7 Treatment 
 
5.7.1 First visit 
 
Where endodontic treatment was indicated, patients were asked to rinse with 0.2% 
chlorhexidene gluconate for 30 seconds.126 Local anaesthetic was administered either 
in the form of local infiltration or nerve block, and rubber dam isolation of the 
affected tooth was performed. 
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All carious tissue was removed from the tooth. The root canal was approached via an 
access cavity preparation that was cut using standard fissure burs, round burs and 
endoflare burs (Micro-Mega9® Besancon, France). 
 
The canals were irrigated using 2.5% sodium hypochlorite, and the irrigation was 
continued throughout the root canal treatment. The canals were cleaned, shaped and 
prepared using the Hero Shaper Rotary System (Micro Mega® Besancon, France), 
with regular irrigation throughout the procedure. The canals were dried using paper 
points.  
 
The canals were obturated when the following criteria were met: 
 
1. Tooth properly isolated to eliminate canal contamination during 
obturation 
2. Canal system cleaned, shaped and dried 
3. Absence of signs and symptoms 
 
If these criteria were met at the first visit, then the canals were obturated using Endo-
Rez® (Ultradent, South Jordan, USA) and the case was deemed a single visit therapy. 
 
The Endorez technique used was as follows: 
 
1. After preparation of the root canal, a master cone was fitted in the wet 
canal to working length in order to achieve a tug-back 
2. The length of the master cone was verified with a periapical radiograph 
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3. The resin sealer was mixed in a double-barrel syringe and was then 
injected into a “skinny syringe” (Ultradent, South Jordan, USA.) 
4. A suitable sized Navi-tip (Ultradent, South Jordan, USA) was selected 
to fit within 3mm of the working length 
5. The sealer was then expressed via the skinny syringe into the canal 
6. The syringe was then slowly withdrawn as the sealer was observed to 
fill-up the canal space 
7. The master cone was then placed in the canal, with lateral 
condensation being used as deemed necessary. 
8. Excess GP and sealer were removed 2-3mm below the CEJ with a 
heated instrument 
 
If the criteria for a single visit treatment were not met, then the canal was medicated 
with pure calcium hydroxide (Tara Minerals, Rajastan, India) using the wipe 
technique and a glass ionomer material was placed temporarily until the second visit. 
 
Glass ionomer restorative material Fuji III (GC, Japan) was used for the provisional 
restoration. The patient was recalled a week later, for further investigation regarding 
the prognosis of the completed procedure by means of radiographic and clinical 
parameters. The criteria included the resolution of signs and symptoms, for example 
no pain, no redness, no swelling in the area. Radiographic criteria included the 
obturation and coronal seal, as determined from postoperative radiographs.   
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The use of antibiotics is not routine in endodontic treatment. However, antibiotic 
therapy was considered only if the following cases presented: 97 
1. Pre-medication situations, for example cardiac prophylaxis 
2. Non-vital pulp in a medically compromised patient 
3. Non-vital pulp with an indurated, non-fluctuant swelling.  
4. Post treatment swelling 
 
5.7.2 Second visit 
 
The patient was again assessed for signs and symptoms after one week. These were 
recorded. Also recorded were the duration and severity of symptoms after the first 
visit. If a single visit treatment had been performed, and all symptoms had been 
resolved, then all other oral health care treatment needs of the patient commenced. 
The final restoration of the endodontically treated tooth was only performed when all 
symptoms had subsided for at least four weeks and a waiting period of four weeks 
was observed. In a multi-visit case, the canals were obturated if the criteria had been 
met. If not, then the canals were irrigated, dried and medicated, and obturation 
postponed to the next visit. This information was recorded. 
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5.7.3 Post-treatment assessment 
 
In order to determine if an endodontically treated tooth was deemed a radiographic 
and clinical success, the criteria below had to be met. The post treatment assessment 
and evaluation were made and noted immediately, as well as after six and eighteen 
months. 
 
5.7.3.1 Criteria for radiographic success 
Immediate: 
1. root canal obturation should be within 1mm of the radiographic apex 
2. sufficient flaring of the coronal two thirds of the canal to demonstrate proper 
technique 
3. absence of voids in the root canal filling 
Long term: 
4. a decrease in the size of the initial peri-apical radiolucency. 
 
5.7.3.2 Clinical success 
 
An absence of symptoms such as pain, swelling, tenderness, sensitivity to thermal 
changes and percussion. 
 
5.8 Statistical analysis 
 
The statistical analysis was carried out on the advice of a statistician, and involved the 
construction of cross tables and testing for significant differences in the presentation 
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of symptoms and endodontic treatment outcomes between the two study groups. 
Although it was found that a proportion of the HIV +ve group of patients presented 
with more than one tooth requiring treatment, and all of the HIV –ve patients 
presented with only one involved tooth each, the analyses were made with the groups 
as the sampling unit. This was because the purpose of the study was to investigate the 
difference in presentation and treatment outcomes as a whole, and any reference to 
individual teeth and their analysis would have distorted the analysis in terms of the 
study objectives.  
 
The following statistical tests were constructed: 
- Chi-square Test of Independence for identifying statistically significant 
relationships between two categorical variables (one dependent and one 
independent variable); 
- Proportional tests using z-values to identify statistically significant difference 
between proportions of two independent groups; 
- Independent Samples T-test for identifying statistically significant differences 
in the averages of a continuous variable (dependent variable) between two 
independent groups, assuming normality in the continuous variable based on 
the Central Limit Theorem; 
- Paired Samples Tests (Exact Tests) for identifying statistically significant 
differences in the averages of a continuous variable (dependent variable) 
between two sparse and unbalanced independent groups. 
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The lower limit of significant difference was set on a 95% level of confidence. SPSS 
for Windows (SPSS Inc., Florida, USA), a statistical software package was used for 
the analysis.   
 
All relevant statistical output can be found in Appendix 4.
 
 
65
CHAPTER 6: RESULTS 
 
6.1 Demography and presenting histories 
 
One hundred and five patients consented to participate in the study; 56% were females 
and 44% males. Initially two patients were discovered to being HIV positive and were 
placed on ART. 
 
Then 44% of the participants were HIV positive and 56% were HIV negative.  Of the 
45 HIV positive patients, 27 (59%) were female and 19 (41%) were male.  Of the 59 
HIV negative patients, 37 (63%) were female and 22 (37%) were male.  The Chi-
square test value (p = 0.676) suggests no significant differences between the two 
groups based on the proportional distribution by gender. The mean age of patients was 
36 years in the HIV positive group and 38 years in the HIV negative group.   
 
Table 6.1 shows the distribution of medical histories. Forty-one in the HIV negative 
sample presented with previous medical conditions in contrast to only 31 of the HIV 
positive patients. Tuberculosis was the most common condition reported amongst the 
HIV positive group (6 cases) and hypertension was the most common condition in the 
HIV negative group (3 cases). None of the medical conditions prevented the patients 
from coming in for the treatment.  
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Table 6.1: Medical histories of HIV negative and HIV positive patients 
 
HIV neg HIV pos
Frequency of 
condition
Frequency of 
condition Total
n = 59 n = 46 n = 105
Med history
Tuberculosis 0 6 7
Migraine 1 4 4
Hypertension on medication 3 1 3
Anaemia 2 0 2
Cancer 0 2 2
Heart valve 2 0 2
Hypertension not on medication 2 0 2
Asthma 0 1 1
Bells palsy 1 0 1
Eczema 1 0 1
Epilepsy 1 0 1
Gastric ulcer 1 0 1
Low BP 1 0 1
Myocardial 0 1 1
Pregnant 1 0 1
Pulmonary infection 1 0 1
Pleural effusion 0 1 1
Thyroid 1 0 1
None 41 31 66
Note: The n-values represent number of patients; some patients presented with more 
than one condition
 
 
Table 6.2 presents the distribution of dental histories amongst the patients.  Forty-two 
of the HIV negative patients presented teeth with caries, whereas only three HIV 
positive patients presented with caries. 
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Table 6.2: Dental history of HIV negative and HIV positive patients 
HIV neg HIV pos
Frequency of 
condition
Frequency of 
condition Total
n = 59 n = 46 n = 105
Dental history
Caries 42 5 47
Clear 0 20 20
Bleeding gums 10 6 16
Crowns 2 0 2
Prosthetic rehab 2 11 13
Extractions 0 2 2
Braces 1 0 1
Broken jaw 1 0 1
Pericoronitis 1 0 1
Attrition 0 1 1
Broken teeth 0 1 1
Fluorosis 0 1 1
Note: The n-values represent number of patients; some patients presented with more 
than one condition
 
 
Table 6.3 presents the number of teeth endodontically treated. The HIV positive 
patients presented on average more than one tooth for endodontic treatment, whereas 
all HIV negative patients only presented one tooth for treatment. 
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Table 6.3: Number of endodontically treated teeth per patient in HIV negative 
and HIV positive patients 
HIV neg HIV pos Total
n = 59 n = 46 n = 105
N umber of teeth treated per patient
One 59 30 89
Two 6 6
Three 4 4
Four 1 1
Five 2 2
Six 2 2
Twelve 1 1
Note: The n-values represent number of patients
 
 
Table 6.4 shows the location of teeth treated in HIV negative and HIV positive 
patients. 
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Table 6.4: Location of teeth treated per patient in HIV negative and HIV positive 
patients 
 
 
HIV neg HIV pos Total
n = 59 n = 92 n = 151
Location of teeth studied
11 3 19 22
12 2 15 17
13 1 6 7
14 1  1
15 6  6
16 1  1
17 1  1
21 2 18 20
22  9 9
23 2 6 8
24 6 2 8
25 4 5 9
26 3  3
31 1 3 4
32 1 1 2
33  2 2
34 2  2
35 1  1
36 6  6
37 3  3
41  2 2
42 1 2 3
43  2 2
44 1 1
45 3 3
46 7 7
47 1 1
Note: The n-values represent number of teeth
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6.2 Results regarding the study objectives 
 
6.2.1 Preoperative presentation of endodontic infections/conditions between 
HIV positive and negative patients 
The first study objective aimed to compare the preoperative presentation of 
endodontic infections/conditions between HIV positive and negative patients 
using clinical and radiographic criteria.   
 
HIV positive patients with more than one tooth involved were aggregated to 
determine the percentage of patients with presenting signs. The results are shown in 
Table 6.5. None of the proportional tests (z-tests) showed significant differences in 
the presentation of pulp pathology between HIV infected patients and healthy (non-
diabetic and non-HIV) controls.  The null-hypothesis can therefore not be rejected, as 
there was no relationship between the presentation of pulp pathology and HIV status.  
Table 6.5: Preoperative presentation of endodontic infections/conditions between 
HIV positive and negative patients 
HIV neg HIV pos p-value Sig.
n = 59 n = 46
Presentation of pulp pathology
Swelling 83% 80% 0.730 N/s
Periapical radiolucency 95% 87% 0.148 N/s
Palpation test 37% 35% 0.791 N/s
Percusion test 88% 87% 0.856 N/s
Cold test 71% 74% 0.757 N/s
Heat test 71% 72% 0.950 N/s
Note: The n-values represent number of patients
*** Significant at p ≤ 0.001
** Significant at p ≤ 0.01
* Significant at p ≤ 0.05
N/s No significance
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6.2.2 Comparison of the outcomes of endodontic therapy between HIV positive 
and negative patients 
 
The second research objective aimed to compare the outcomes of endodontic 
therapy between the two groups.   
 
Table 6.7 shows significant differences between the HIV positive and HIV negative 
groups in two of the five outcomes studied, but not in the overall success rates at 18 
months.   
 
Table 6.6: Comparison of the outcomes of endodontic therapy between HIV 
positive and negative patients at recall 
 
HIV neg HIV pos p-value Sig.
n = 59 n = 46
Outcome of endodontic therapy
palpation 5% 4% 0.860 N/s
percussion 3% 17% 0.015 *
hot/cold 3% 15% 0.032 *
remaining radiographic evidence 10% 2% 0.103 N/s
overall success rate at 18 mths 78% 62% 0.057 N/s
Note: The n-values represent number of patients
*** Significant at p ≤ 0.001
** Significant at p ≤ 0.01
* Significant at p ≤ 0.05
N/s No significance
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6.2.4 Comparison of the presentation and outcomes of endodontic infections by 
HIV positive patients with their different CD4 counts 
 
Table 6.7 shows that no significant differences were observed in the average CD4 
counts between groups that presented with positive and negative post endodontic 
treatment symptoms of the HIV positive group. However, the data appeared to show a 
trend, and at 90% probability level, there were differences in the symptoms relating to 
pain (palpation, percussion, hot/cold) with the patients experiencing pain having 
lower CD4 counts. 
 
Table 6.7: Comparison of the presentation and outcomes of endodontic infections 
by HIV positive patients with their different CD4 counts 
 
p-value Sig.
n Mean SD
Excess bleeding
No 8 439 156
Yes 38 362 210 0.181 N/s
Recall palpation
No 44 378 202
Yes 2 320 273 0.591 N/s
Recall percussion
No 38 398 211
Yes 8 268 110 0.201 N/s
Recall hot/cold
No 39 386 209
Yes 7 317 157 0.632 N/s
Recall radiographic appearance
Unclear 1 220 .
Clear 45 379 203 0.435 N/s
Note: The n-values represent number of patients
*** Significant at p ≤ 0.001
** Significant at p ≤ 0.01
* Significant at p ≤ 0.05
N/s No significance
CD4 Count
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The hypothesis also considered the difference in the CD4 count before and after 
endodontic treatment of HIV infected patients.  Table 6.9 shows that the post endodontic 
CD4 counts are significantly higher than CD4 counts measured prior to treatment (375 
compared to 295, p = 0.000). All the patients were receiving ART throughout the course 
of the study. 
 
Table 6.8: Pre and post treatment CD4 counts in HIV patients 
HIV pos
n = 46
CD4 (Pre)
Mean 295
SD 183
CD4 (Post)
Mean 375
SD 202
p-value 0.000
Sig. ***
Note: The n-values represent number of patients
*** Significant at p ≤ 0.001
** Significant at p ≤ 0.01
* Significant at p ≤ 0.05
N/s No significance
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CHAPTER 7: DISCUSSION 
Current HIV statistics in the South African population 108 show that the average age, with 
the HIV positive adult population lies within the age group of 15-36 years of age, which 
was the case with the HIV positive group in this study.  HIV statistics also show that 
women of all ages are more vulnerable to HIV/AIDS than men.108 
 
Although symptoms of pain severity showed no statistically significant difference at a 
95% confidence level between the two groups of patients, a difference was observed at a 
90% level for the experience of pain classified as severe.  This response could be 
attributed to the low immuno-compromised state of the HIV patients and to the finding 
that infection in the HIV positive group was more severe and involved multiple teeth. 
Symptoms for pulp pathology showed no statistically significant difference between HIV 
positive and HIV negative patients.  This result was also found in a study by 
Zakrzewskacxxvii, where HIV patients presented with symptoms similar to HIV negative 
patients. 
 
Considerable progress has been made with respect to the use of antibiotics in endodontic 
patients 31. In this study only patients presenting with swellings and severe pain were 
given antibiotics (penicillin) and root canal therapy was done as a two stage procedure. 
Shabehang 31 found that 80 to 95 percent of cultivable endodontic microorganisms 
remain sensitive to penicillin, supporting the use of penicillin in this study. According to 
Scully, Porter and Lukercxxviii in HIV patients, root canal therapy should be done as a 
one-stage procedure with antibiotic cover in symptomatic patients. Coo er p her 99 on the ot
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hand advocated that antibiotic prophylaxis is not routinely required in HIV patients 
undergoing root canal treatment. However, the slow healing rate, the severity of pain and 
lower success rates of endodontic treatment in this study support the idea that all HIV 
patients should receive antibiotic treatment before root canal therapy. 
 
Length of the roots showed no difference between the two groups of patients. This can be 
due to the fact that root morphology has no association to the HIV status of a patient. In 
all cases root development had taken place before the patient contracted HIV. It may be 
useful to conduct studies in children in order to explore any relationship between HIV 
and tooth development. 
 
The fact that oral lesions of a fungal, bacterial and viral nature occur in up to 80% of the 
HIV positive population, makes the oral environment more susceptible to all types of 
infections. Furthermore xerostomia is a common side effect of anti-retroviral therapy 
(ART) which can result in the activation of endogenous organisms.128 According to a 
study by Fukushima et al,cxxix it seems apparent that microorganisms can reach the heart 
valves by a process known as anachoresis (bacterial localization) whereby the 
microorganisms are carried via the bloodstream to heart valves. Similarly it has been 
shown that in diabetic patients microorganisms are carried via the bloodstream to the 
dental pulp via the anachoretic process.91 The concept of anachoresis goes back as far as 
1867 when it was demonstrated that systemic bacteria were able to enter inflamed dental 
pulps,cxxx and non-carious teeth showed symptoms of requiring endodontic treatment. 
The process of anachoresis only occurs where there is adequate blood circulation.cxxx 
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 In this study, it would appear that this process was also occurring in the HIV positive 
group. Although caries was common in both groups, a large number of the HIV positive 
patients presented with a history of no dental complications and yet required endodontic 
treatment. Radiographic findings further confirmed that caries was found less commonly 
in the symptomatic teeth in the HIV positive group compared with the HIV negative 
group. Radiographic caries was a very significant finding, in that in the HIV negative 
group (71.2%) most teeth that were endodontically involved showed radiographic caries 
whereas in the HIV positive group only (10.9%) of teeth that were endodontically 
involved showed radiographic caries.  
 
The HIV positive patients presented mainly with single rooted teeth whereas in the HIV 
negative patients multi-rooted teeth were involved. Furthermore anterior teeth were 
endodontically involved in the HIV positive group of patients who presented with severe 
symptoms requiring immediate treatment. This accords with a study by Suchina et al, 
cxxxi  where episodically treated HIV positive patients underwent five times as many 
anterior endodontic procedures compared with routinely treated HIV-infected patients. 
This would seem to imply that HIV positive patients are more susceptible to endodontic 
infection of multiple anterior teeth. 
 
Excessive bleeding after preparation of the root canals occurred mainly in the HIV 
positive group (83%). This could be attributed to haematological abnormalities of the 
HIV positive patients resulting in poor healing processes.cxxxii Considering that all HIV 
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patients were on ART it could also be attributed to anemia, a side effect of the ART.cxxxii 
This finding has not been reported on before and requires further investigation.  
 
There were statistically significant differences when the success/failure of the root canal 
therapy was related to symptomatic clinical presentation 18-months after treatment. On 
the 18-month recall visit, a high number of HIV positive patients presented with 
sensitivity to percussion (17%) and sensitivity to heat and cold (15%), compared with 
very low numbers in the HIV negative group (3%) presenting with these symptoms. This 
could be interpreted as being a result of the immunocompromised state of the patients, 
which could have influenced the rate of healing. A study by Shetty, Garcia and 
Leighcxxxiii however found that no statistically significant differences were noted when 
the success of the root canal therapy was related to the symptomatic clinical presentation. 
 
Levinecxxxiv found that progression of a periradicular lesion from an acute phase to a 
chronic phase resulted in a significant decrease in the number of CD4 cells within the 
periapical lesion. Although that study was done in cats, it is interesting to note that in the 
present study it was found that CD4 cell counts taken prior to treatment and 18-months 
after the completion of treatment, showed a significant increase in CD4 cell counts 18-
months after endodontic treatment in the HIV patients. As all HIV patients received ART 
throughout the length of the study, the increase in CD4 counts could be due to the 
resolution of the infection. However, the healing process was still slow even though the 
CD4 counts increased substantially. This slow healing process could be attributed to the 
hypothesis that the degree of inflammation and progression of the periapical lesion was 
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more intense in the HIV patients as compared to the HIV negative patients. This finding 
calls for further research in a larger population group.  
 
 
CHAPTER 8: CONCLUSIONS 
 
Within the limitations of this study the following conclusions emerge: 
 
5. Although the success rate was lower over the period of this study in HIV positive 
patients, there was no significant difference in the overall outcome in this group 
of patients compared with the HIV negative group. The rate is sufficiently high to 
warrant treatment. 
6. However, patients who are HIV positive may present with more severe symptoms 
and during treatment more bleeding may be expected. 
7. In keeping with best practice for immuno-compromised patients, it would be 
advantageous to put HIV positive patients on antibiotic cover during treatment. 
8. The process of anachoresis may explain the high incidence of endodontic 
infections in teeth with no history of trauma or caries in patients who are HIV 
positive. 
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SUBJECT INFORMATION FORM 
 
Hello, name is Dr. S Tootla from the Restorative Dentistry Department. I am doing a 
research study on root canal treatments (removal of the infected nerve within the tooth) 
comparing patients who have been infected with the human immunodeficiency virus 
(HIV), who are referred to as seropositive and those who are not infected, referred to as 
seronegative. I would like to inform you about this study and invite you to participate. 
You may decide whether you are willing to take part or not.  
 
In order to compare the seropositive with the seronegative group, we will need to perform 
an HIV test on you after an appropriate counseling. This entails taking a small sample of 
blood (Approximately one tablespoon), which will be sent to a laboratory for testing. 
Your test results will be kept confidential. If you have already been tested, we request 
your permission to check your results. Irrespective of your HIV status, you will be 
allowed to participate in this study. HIV is very common in South Africa. The rate of 
endodontic lesions (infected area) is higher in seropositive individuals compared to 
seronegative individuals. The chances of  developing this infection can be reduced by 
improving the general Oral Health status of the individual after appropriate education. 
Antibiotic treatment may also be necessary. This study will help in defining other ways 
of preventing and managing this problem. 
 
In order to understand this study, I would like to examine your mouth, take an X-Ray of 
the appropriate tooth/teeth, explain to you how to brush your teeth correctly and give you 
a toothbrush and toothpaste. Furthermore, antibiotic therapy will be prescribed. You will 
be asked to return after one week when another X-Ray will be taken, and endodontic 
treatment (removal of the infected nerve) will commence to completion. At this stage a 
paper point will be used to take a bacterial sample the root canal space. This sample will 
be transported to the Microbiology Laboratory. This will allow us to determine the type 
of infection present. You will then be asked to return after one month and three months 
consecutively when further      X-Rays and examinations of the root canal treated tooth 
will proceed. I will be present at every visit in order to explain your treatment and 
progress, and conduct the treatment. You will be asked to visit our clinic for four 
appointments. At these visits, a clinical examination and   intra-oral X-Rays (X-Rays of 
the specific tooth/teeth) will be done, together with the required endodontic procedure. 
The healing rate of the endodontic lesion and treatment will be documented and 
compared in the seropositive and seronegative individuals. 
 
The endodontic treatment should not cause pain or harm you in any way. Rather it should 
help to alleviate any pain or associated discomfort that may have been present in the 
involved tooth/teeth. 
 
Participation in this study is entirely voluntary. Refusal to participate will not affect your 
required dental treatment in any way. You may discontinue or withdraw at any stage or 
time during the study, without prejudice to the treatment you are receiving. If you have 
any queries or questions with regard to this study, kindly contact me at the following 
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number 072 2318185. If you are willing to participate in the study, please read and sign 
the informed consent form.  
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INFORMED CONSENT FORM 
 
The aims and procedure or the study that I have been to take part in have been explained 
to me by ………………………………………………………………… 
I have had the opportunity to ask questions and to consider the answers given. I 
understand that participation in this study is entirely voluntary. 
I understand that I can withdraw from the study at any time, should that be necessary. 
 
I hereby freely give my informed consent to take part in this study. 
 
NAME OF PATIENT:……………………………………      DATE:……………….. 
 
SIGNATURE:…………………………. 
 
 
I confirm that I have explained the nature of the above study to the above named patient. 
 
NAME OF DENTIST:…………………………………….      DATE:………………… 
 
SIGNATURE:…………………………... 
 
 
 
1………………………………………….                                 DATE…………………. 
WITNESS 
 
 
2………………………………………….                                 DATE………………….. 
WITNESS 
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AFFIDAVIT FOR HIV TESTING 
 
 
I,……………………………………………………………………. hereby confirm that 
 
Dr…………………………………………………………………… has discussed HIV  
infection with me, including its implications and its possible complications on my life. 
 
 
I understand that testing is voluntary, and I give permission to have my blood tested for 
HIV 
 
                                                                  OR 
 
I have already been tested for HIV. I give permission to Dr. Saidah Tootla to check my 
results. 
 
 
SIGNATURE OF PATIENT:……………………………………      
DATE:…………………. 
 
SIGNATURE OF DENTIST:……………………………………      
DATE:…………………. 
 
SIGNATURE OF WITNESS:…………………………………...      
DATE:………………….. 
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No   
    
Date of Birth 
                                                          
Age: 
ID Number                
Home Add   
  
                                                         
Code: 
Postal Add   
  
                                                         
Code: 
Tel: Home                                        Work: 
Cell Number   
Bussiness: Company   
                    Address   
Occupation   
Medical Aid   
Medical Aid Number   
Medical Doctor   
Regular clinic/hospital                                       Tel: 
    
Emerg contact person                                       Tel: 
    
  
Medical History   
    
Dental History   
    
H status   
CD4 counts Date:                              Count: 
  Date:                              Count: 
  Date:                              Count: 
  Date:                              Count: 
  Date:                              Count: 
    
Extraoral exam   
Swelling   
Facial asymmetry   
TMJ   
Muscles of Mastc   
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                            ENDODONTIC DATA 
                                PAIN HISTORY 
Pain History   
Date of onset of sympt   
Severity    
Heat/Cold/Sweet   
Spontaneous pain   
Awake at night   
Pain on chewing   
Discription of pain Dull 
  Sharp 
  Throbbing 
  
  
                           SIGNS OF INFECTION 
Swelling   
Size of swelling   
Nature of swelling  Soft:                         Hard: 
Anatomical Position   
Duration of swelling   
    
Temperature   
Sinus tract   
Drainage   
Lymph adenopathy   
  
                    GENERAL CONDITIONS OF MOUTH 
Dental status   
    
Periodontal condition   
Oral hygiene status   
Occlusion   
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       AFFECTED TOOTH: TOOTH NUMBER                                     
Caries   
Restoration    
Pulp involvement   
Trauma   
Restorability/Prognosis   
Occlusal status   
Perio-Endo lesion   
Pocket depths   
Furcation involvement   
Periodontal prognosis   
  
  
  
                            ENDODONTIC TESTS 
Percussion test   
Mobility test   
Cold test   
Heat test    
Tooth Fracture Test   
  
                        RADIOGRAPHIC FINDINGS 
Caries   
Restoration    
Periradicular lesion   
  
Furcation lesion   
    
Pulp space   
Chamber anatomy   
Calcifications   
Number of canals   
Canals 
sclerozed/patent   
Root Morphology   
Curvature   
Length of roots    
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                                   DIAGNOSIS 
Normal pulp   
Reversible pulpitis   
Irreversible Pulpitis   
Necrotic pulp   
Peri-radicular   
Perio-endo lesion   
Previous Endo 
treatment   
  
WORK RECORD  
                                 FIRST VISIT 
                                TREATMENT 
Caries removal   
Access cavity   
PP swab for PCR   
Pulp removal   
Canals explored   
    
    
Canal medication    
Temporary seal   
Antibiotics   
  
TIME TAKEN FOR PROCEDURE:…………………………………..MINS 
MATERIALS USED  AMOUNT 
Local anaesthetic   
Rubber dam   
Burs   
Irrigating solutions   
Medicaments   
Temporary seal   
Files   
X-Rays   
GP   
Sealant   
  
  
  
 
 
  
  
  
  
 
 
111
                                                                                                                                                 
                                                        SECOND VISIT 
Symptoms   
Time symptoms   
Swelling    
Sinus tract   
Mobility   
Percussion test   
  
                       TREATMENT 
Caries removal   
Access cavity   
PP swab for PCR   
Pulp removal   
Canal medication   
Temporary seal   
Antibiotics   
    
Time for procedure   
  
MATERIALS AMOUNT OF MATERIAL 
Local anaesthetic   
Rubber dam   
Burs   
Irrigating solutions   
Medicaments   
Temporary seal    
Files   
X-Rays   
GP   
Sealant   
  
  OBTURATION RECORD 
Canal  
WL                     Size                         
Taper 
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